Tumor profiling using Next Generation Sequencing (NGS) is rapidly gaining importance in molecular pathology.
Adopting this technology requires not only new wet-lab workflows and solutions, but also bioinformatics tools to analyze, interpret, and database the large number of variants originating from NGS assays. It also brings challenges in data management and clinical interpretation.
Because fast-turnaround time in a cancer diagnostic setting is essential, our eSeminars are designed to quickly bring you and your team up to speed on NGS .
Delivering actionable results that are clinically robust--informed, traceable and reproducible—is within your lab’s reach with Agilent.